BioNTech also laid off 63 employees in June in conjunction with the discontinuation of its cell therapy manufacturing ...

Victoria is cementing its position as a global hub for biotechnology and life sciences, with BioNTech establishing a state-of ...

One vaccine expert called the move, which cancels some $500 million in messenger RNA research contracts, a “giant step ...

BioNTech SE BNTX -0.15% Get Free Report reported a narrower loss for the second quarter on Monday. The company posted a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, versus a loss of ...

BMY trims earnings outlook despite revenue beat and upbeat drug sales, sending shares to a 52-week low before a rebound. We ...

Kennedy’s newest decision comes amid a string of vaccine pullbacks at the health department in recent months. In May, he said ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

The US is withdrawing $500m for vaccines for diseases like flu and Covid. Health correspondent James Gallagher asks if it's ...

Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to ...

The Allan Labor Government has welcomed a new BioNTech clinical trial platform that will provide cancer patients with easier access to the next ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...